• 1
    Bilimoria M, Morrow M: The woman at increased risk for breast cancer: Evaluation and management strategies. Ca Cancer J Clin 1995; 45: 263278.
  • 2
    Seidman H, Mushinski MH, Gelb SK, Silverberg E: Probabilities of eventually developing or dying of cancer: United States, 1985. CA Cancer J Clin 1985; 35: 3656.
  • 3
    Marcus JN, Watson P, Page DL, Lynch HT: Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Inst 1994; 16: 2334.
  • 4
    Newman B, Austin MA, Lee M, King MC: Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A 1988; 85: 30443048.
  • 5
    Strong LC: The cloning of BRCA1 and localization of BRCA2: The race is over, but the long search to understand the genes' roles in breast cancer is just beginning. Breast Diseases: A Year Book Quarterly 1995; 6: 139141.
  • 6
    Hutter R: Consensus meeting: Is “fibrocystic disease” of the breast precancerous?. Arch Pathol Lab Med 1986; 110: 171173.
  • 7
    Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative disease. N Engl J Med 1985; 312: 146151.
  • 8
    Easton DF, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 1993; 52: 678701.
  • 9
    Temple WJ, Lindsay RL, Magi E, Urbanski SJ: Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg 1991; 161: 413415.
  • 10
    Snyderman RK: Prophylactic mastectomy: Pros and cons. Cancer 1984; 53 (suppl 3): 803808.
  • 11
    Wong JH, Jackson CF, Swanson JS, et al: Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer. Surgery 1986; 99: 6771.
  • 12
    Nelson H, Miller SH, Buck D, et al: Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H mice. Plast Reconstr Surg 1989; 83: 662669.